Two Sigma Advisers’s Albireo Pharma, Inc. Common Stock ALBO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,000
| Closed | -$238K | – | 2826 |
|
|
2022
Q4 | $238K | Sell |
11,000
-900
| -8% | -$19.4K | ﹤0.01% | 2137 |
|
|
2022
Q3 | $230K | Sell |
11,900
-14,100
| -54% | -$273K | ﹤0.01% | 2158 |
|
|
2022
Q2 | $516K | Sell |
26,000
-18,200
| -41% | -$361K | ﹤0.01% | 1909 |
|
|
2022
Q1 | $1.32M | Sell |
44,200
-1,900
| -4% | -$56.7K | ﹤0.01% | 1484 |
|
|
2021
Q4 | $1.07M | Sell |
46,100
-24,800
| -35% | -$578K | ﹤0.01% | 1530 |
|
|
2021
Q3 | $2.21M | Sell |
70,900
-82,700
| -54% | -$2.58M | 0.01% | 1194 |
|
|
2021
Q2 | $5.4M | Sell |
153,600
-58,300
| -28% | -$2.05M | 0.01% | 830 |
|
|
2021
Q1 | $7.47M | Buy |
211,900
+10,200
| +5% | +$360K | 0.02% | 689 |
|
|
2020
Q4 | $7.57M | Buy |
201,700
+163,000
| +421% | +$6.11M | 0.02% | 667 |
|
|
2020
Q3 | $1.29M | Buy |
38,700
+17,100
| +79% | +$570K | ﹤0.01% | 1384 |
|
|
2020
Q2 | $572K | Buy |
21,600
+4,600
| +27% | +$122K | ﹤0.01% | 1833 |
|
|
2020
Q1 | $278K | Buy |
17,000
+6,700
| +65% | +$110K | ﹤0.01% | 2044 |
|
|
2019
Q4 | $262K | Buy |
+10,300
| New | +$262K | ﹤0.01% | 2105 |
|
|
2014
Q2 | – | Sell |
-670
| Closed | -$54K | – | 2129 |
|
|
2014
Q1 | $54K | Sell |
670
-113
| -14% | -$9.11K | ﹤0.01% | 1684 |
|
|
2013
Q4 | $54K | Buy |
+783
| New | +$54K | ﹤0.01% | 1738 |
|